These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 1596561)

  • 1. Interleukin-5, eosinophils, and disease.
    Sanderson CJ
    Blood; 1992 Jun; 79(12):3101-9. PubMed ID: 1596561
    [No Abstract]   [Full Text] [Related]  

  • 2. Airway hyperresponsiveness: first eosinophils and then neuropeptides.
    Kraneveld AD; Folkerts G; Van Oosterhout AJ; Nijkamp FP
    Int J Immunopharmacol; 1997; 19(9-10):517-27. PubMed ID: 9637348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophils and the lung.
    Bertorelli G; Pesci A
    Monaldi Arch Chest Dis; 1994 Jun; 49(3):221-6. PubMed ID: 8087119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-5: a proeosinophil cytokine mediator of inflammation in asthma and a target for antisense therapy.
    Weltman JK; Karim AS
    Allergy Asthma Proc; 1998; 19(5):257-61. PubMed ID: 9801738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophils negatively regulate eosinophilopoiesis by decreasing IL-5 levels.
    Enokihara H; Koike T; Nakamura Y; Yamashiro K; Tsuruoka N; Saito K; Furusawa S
    Int Arch Allergy Immunol; 1996; 111 Suppl 1():2-4. PubMed ID: 8906102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma.
    Menzies-Gow A; Robinson DS
    Curr Opin Pulm Med; 2002 Jan; 8(1):33-8. PubMed ID: 11753121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of defective eosinophil apoptosis in diseases associated with eosinophilia.
    Simon HU
    Int Arch Allergy Immunol; 1997; 113(1-3):206-8. PubMed ID: 9130524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular regulation of eosinophil trafficking to the lung.
    Hogan SP; Mould AW; Young JM; Rothenberg ME; Ramsay AJ; Matthaei K; Young IG; Foster PS
    Immunol Cell Biol; 1998 Oct; 76(5):454-60. PubMed ID: 9797467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary biology of anti-interleukin 5 antibodies.
    Egan RW; Athwahl D; Chou CC; Chapman RW; Emtage S; Jenh CH; Kung TT; Mauser PJ; Murgolo NJ; Bodmer MW
    Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():69-73. PubMed ID: 9698918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
    Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
    Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.
    Mould AW; Matthaei KI; Young IG; Foster PS
    J Clin Invest; 1997 Mar; 99(5):1064-71. PubMed ID: 9062365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elemental signals regulating eosinophil accumulation in the lung.
    Foster PS; Mould AW; Yang M; Mackenzie J; Mattes J; Hogan SP; Mahalingam S; Mckenzie AN; Rothenberg ME; Young IG; Matthaei KI; Webb DC
    Immunol Rev; 2001 Feb; 179():173-81. PubMed ID: 11292021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-5-induced airway eosinophilia--the key to asthma?
    Hamelmann E; Gelfand EW
    Immunol Rev; 2001 Feb; 179():182-91. PubMed ID: 11292022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal eosinophils in health and disease.
    Rothenberg ME; Mishra A; Brandt EB; Hogan SP
    Adv Immunol; 2001; 78():291-328. PubMed ID: 11432207
    [No Abstract]   [Full Text] [Related]  

  • 15. Eosinophil trafficking to sites of allergic inflammation.
    Broide D; Sriramarao P
    Immunol Rev; 2001 Feb; 179():163-72. PubMed ID: 11292020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence of the harmful effects of eosinophils in bronchial asthma].
    Mehić B; Konjicija A; Zutić H; Lukić Z
    Plucne Bolesti; 1990; 42(1-2):104-6. PubMed ID: 2217619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-5 priming of eosinophil function in asthma.
    Sampson AP
    Clin Exp Allergy; 2001 Apr; 31(4):513-7. PubMed ID: 11359415
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-5 messenger RNA expression in peripheral blood mononuclear cells from patients with bronchial asthma and eosinophilia.
    Ishizuka T; Ishizuka T; Iwamae S; Hisada T; Okayama Y; Tsukagoshi H; Dobashi K; Mori M
    Allergy Asthma Proc; 2002; 23(3):175-9. PubMed ID: 12125504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma.
    Mauser PJ; Pitman A; Witt A; Fernandez X; Zurcher J; Kung T; Jones H; Watnick AS; Egan RW; Kreutner W
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1623-7. PubMed ID: 7504892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5.
    Tomkinson A; Kanehiro A; Rabinovitch N; Joetham A; Cieslewicz G; Gelfand EW
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1283-91. PubMed ID: 10508820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.